New trial tests whether exposing peanut-allergic kids to tiny doses builds tolerance

Researchers are running a controlled study on slow immunotherapy for young children with peanut allergies, gradually introducing minute amounts to train immune systems. Success could reshape treatment for one of the most common and dangerous childhood allergies, potentially reducing reliance on emergency epinephrine and expanding safe food options.

Originaltitel: Randomized controlled trial of slow peanut oral immunotherapy in young children: SmaChO study protocol